The use of a
probiotic strain of
Lactobacillus rhamnosus and an
oligosaccharide mixture which comprises 5-70 wt % of at least one N-acetylated
oligosaccharide selected from the group comprising GalNAcα1,3Galβ1,4Glc and Galβ1,6GalNAcα1,3Galβ1,4Glc, 20-90 wt % of at least one neutral
oligosaccharide selected from the group comprising Galβ1,6Gal, Galβ1,6Galβ1,4Glc Galβ1,6Galβ1,6Glc, Galβ1,3Galβ1,3Glc, Galβ 1,3Galβ 1,4GIc, Galβ 1,6Galβ 1,6Galβ 1,4GIc, Galβ 1,6Galβ 1,3Galβ 1,4GIc Galβ1,3Galβ1,6Galβ1,4Glc and Galβ1,3Galβ1,3Galβ1, 4GIc and 5-50 wt % of at least one sialylated oligosaccharide selected from the group comprising NeuAcα2,3Galβ1,4GIc and NeuAcα2,6Galβ1,4Glc in the manufacture of a medicament or therapeutic
nutritional composition for promoting the development of an early bifidogenic intestinal microbiota in infants delivered by
caesarean section is disclosed.